 | • レポートコード：MRC2211A123 • 出版社/出版日：Transparency Market Research / 2022年8月 • レポート形態：英文、PDF、257ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| トレンスペアレンシーマーケットリサーチ社の当調査レポートでは、世界のビタミンD検査市場を総合的に調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、検査タイプ別（25-ヒドロキシDビタミン、1,25-ジヒドロキシDビタミン）分析、技術別（ラジオイムノアッセイ、ELISA、HPLC、LC-MS、その他）分析、エンドユーザー別（病院、診断研究室、在宅医療、ポイントオブケア、その他）分析、疾患別（骨粗鬆症、くる病、甲状腺疾患、吸収不良、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの内容を掲載しています。なお、当書には、DiaSorin S.p.A.、DiaSys Diagnostic Systems GmbH、bioMérieux SA、Bio-Rad Laboratories、Abbott Laboratories、Siemens Healthineers、F. Hoffmann-La Roche Ltd、Thermo Fisher Scientific, Inc.、Quest Diagnostics Incorporated、Danaher Corporationなどの企業情報が含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界のビタミンD検査市場規模：検査タイプ別 - 25-ヒドロキシDビタミン検査の市場規模 - 1,25-ジヒドロキシDビタミン検査の市場規模 ・世界のビタミンD検査市場規模：技術別 - ラジオイムノアッセイの市場規模 - ELISAの市場規模 - HPLCの市場規模 - LC-MSの市場規模 - その他技術の市場規模 ・世界のビタミンD検査市場規模：エンドユーザー別 - 病院における市場規模 - 診断研究室における市場規模 - 在宅医療における市場規模 - ポイントオブケアにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界のビタミンD検査市場規模：疾患別 - 骨粗鬆症における市場規模 - くる病における市場規模 - 甲状腺疾患における市場規模 - 吸収不良における市場規模 - その他疾患における市場規模 ・世界のビタミンD検査市場規模：地域別 - 北米のビタミンD検査市場規模 - ヨーロッパのビタミンD検査市場規模 - アジア太平洋のビタミンD検査市場規模 - 中南米のビタミンD検査市場規模 - 中東・アフリカのビタミンD検査市場規模 ・競争状況 |
Vitamin D Testing Market – Scope of Report
TMR’s report on the global vitamin D testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global vitamin D testing market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global vitamin D testing market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the vitamin D testing market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global vitamin D testing market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global vitamin D testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global vitamin D testing market.
The report delves into the competitive landscape of the global vitamin D testing market. Key players operating in the global vitamin D testing market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global vitamin D testing market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market vitamin D testing.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Vitamin D Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Vitamin D Testing Market Analysis and Forecast, 2017 – 2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Developments
5.2. Vitamin D Deficiency Prevalence
5.3. Healthcare Industry Overview
5.4. Vitamin D Tests – Product Life Cycle
5.5. Covid 19 Impact Analysis
6. Global Vitamin D Testing Market Analysis and Forecast, by Test Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Test Type, 2017 – 2031
6.3.1. 25-Hydroxy D Vitamin
6.3.2. 1,25- Dihydroxy D Vitamin
6.4. Market Attractiveness, by Test Type
7. Global Vitamin D Testing Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017 – 2031
7.3.1. Hospitals
7.3.2. Diagnostic Laboratories
7.3.3. Home-care
7.3.4. Point-of-care
7.3.5. Others
7.4. Market Attractiveness, by End-user
8. Global Vitamin D Testing Market Analysis and Forecast, by Technique
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Technique, 2017 – 2031
8.3.1. Radioimmunoassay
8.3.2. ELISA
8.3.3. HPLC
8.3.4. LC-MS
8.3.5. Others
8.4. Market Attractiveness, by Technique
9. Global Vitamin D Testing Market Analysis and Forecast, by Patient Type
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Patient Type, 2017 – 2031
9.3.1. Adult
9.3.2. Pediatric
9.4. Market Attractiveness, by Patient Type
10. Global Vitamin D Testing Market Analysis and Forecast, by Indication
10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Market Value Forecast, by Indication, 2017 – 2031
10.3.1. Osteoporosis
10.3.2. Rickets
10.3.3. Thyroid disorders
10.3.4. Malabsorption
10.3.5. Vitamin D Deficiency
10.3.6. Others
10.4. Market Attractiveness, by Indication
11. Global Vitamin D Testing Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness, by Country/Region
12. North America Vitamin D Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Test Type, 2017 – 2031
12.2.1. 25-Hydroxy D Vitamin
12.2.2. 1,25- Dihydroxy D Vitamin
12.3. Market Value Forecast, by End-user, 2017 – 2031
12.3.1. Hospitals
12.3.2. Diagnostic Laboratories
12.3.3. Home-care
12.3.4. Point-of-care
12.3.5. Others
12.4. Market Value Forecast, by Technique, 2017 – 2031
12.4.1. Radioimmunoassay
12.4.2. ELISA
12.4.3. HPLC
12.4.4. LC-MS
12.4.5. Others
12.5. Market Value Forecast, by Patient Type, 2017 – 2031
12.5.1. Adult
12.5.2. Pediatric
12.6. Market Value Forecast, by Indication, 2017 – 2031
12.6.1. Osteoporosis
12.6.2. Rickets
12.6.3. Thyroid disorders
12.6.4. Malabsorption
12.6.5. Vitamin D Deficiency
12.6.6. Others
12.7. Market Value Forecast, by Country, 2017 – 2031
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Test Type
12.8.2. By End-user
12.8.3. By Technique
12.8.4. By Patient Type
12.8.5. By Indication
12.8.6. By Country
13. Europe Vitamin D Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Test Type, 2017 – 2031
13.2.1. 25-Hydroxy D Vitamin
13.2.2. 1,25- Dihydroxy D Vitamin
13.3. Market Value Forecast, by End-user, 2017 – 2031
13.3.1. Hospitals
13.3.2. Diagnostic Laboratories
13.3.3. Home-care
13.3.4. Point-of-care
13.3.5. Others
13.4. Market Value Forecast, by Technique, 2017 – 2031
13.4.1. Radioimmunoassay
13.4.2. ELISA
13.4.3. HPLC
13.4.4. LC-MS
13.4.5. Others
13.5. Market Value Forecast, by Patient Type, 2017 – 2031
13.5.1. Adult
13.5.2. Pediatric
13.6. Market Value Forecast, by Indication, 2017 – 2031
13.6.1. Osteoporosis
13.6.2. Rickets
13.6.3. Thyroid disorders
13.6.4. Malabsorption
13.6.5. Vitamin D Deficiency
13.6.6. Others
13.7. Market Value Forecast, by Country/Sub-region, 2017 – 2031
13.7.1. Germany
13.7.2. U.K.
13.7.3. France
13.7.4. Spain
13.7.5. Italy
13.7.6. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Test Type
13.8.2. By End-user
13.8.3. By Technique
13.8.4. By Patient Type
13.8.5. By Indication
13.8.6. By Country/Sub-region
14. Asia Pacific Vitamin D Testing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Test Type, 2017 – 2031
14.2.1. 25-Hydroxy D Vitamin
14.2.2. 1,25- Dihydroxy D Vitamin
14.3. Market Value Forecast, by End-user, 2017 – 2031
14.3.1. Hospitals
14.3.2. Diagnostic Laboratories
14.3.3. Home-care
14.3.4. Point-of-care
14.3.5. Others
14.4. Market Value Forecast, by Technique, 2017 – 2031
14.4.1. Radioimmunoassay
14.4.2. ELISA
14.4.3. HPLC
14.4.4. LC-MS
14.4.5. Others
14.5. Market Value Forecast, by Patient Type, 2017 – 2031
14.5.1. Adult
14.5.2. Pediatric
14.6. Market Value Forecast, by Indication, 2017 – 2031
14.6.1. Osteoporosis
14.6.2. Rickets
14.6.3. Thyroid disorders
14.6.4. Malabsorption
14.6.5. Vitamin D Deficiency
14.6.6. Others
14.7. Market Value Forecast, by Country/Sub-region, 2017 – 2031
14.7.1. China
14.7.2. Japan
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
14.8.1. By Test Type
14.8.2. By End-user
14.8.3. By Technique
14.8.4. By Patient Type
14.8.5. By Indication
14.8.6. By Country/Sub-region
15. Latin America Vitamin D Testing Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Test Type, 2017 – 2031
15.2.1. 25-Hydroxy D Vitamin
15.2.2. 1,25- Dihydroxy D Vitamin
15.3. Market Value Forecast, by End-user, 2017 – 2031
15.3.1. Hospitals
15.3.2. Diagnostic Laboratories
15.3.3. Home-care
15.3.4. Point-of-care
15.3.5. Others
15.4. Market Value Forecast, by Technique, 2017 – 2031
15.4.1. Radioimmunoassay
15.4.2. ELISA
15.4.3. HPLC
15.4.4. LC-MS
15.4.5. Others
15.5. Market Value Forecast, by Patient Type, 2017 – 2031
15.5.1. Adult
15.5.2. Pediatric
15.6. Market Value Forecast, by Indication, 2017 – 2031
15.6.1. Osteoporosis
15.6.2. Rickets
15.6.3. Thyroid disorders
15.6.4. Malabsorption
15.6.5. Vitamin D Deficiency
15.6.6. Others
15.7. Market Value Forecast, by Country/Sub-region, 2017 – 2031
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Rest of Latin America
15.8. Market Attractiveness Analysis
15.8.1. By Test Type
15.8.2. By End-user
15.8.3. By Technique
15.8.4. By Patient Type
15.8.5. By Indication
15.8.6. By Country/Sub-region
16. Middle East & Africa Vitamin D Testing Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Test Type, 2017 – 2031
16.2.1. 25-Hydroxy D Vitamin
16.2.2. 1,25- Dihydroxy D Vitamin
16.3. Market Value Forecast, by End-user, 2017 – 2031
16.3.1. Hospitals
16.3.2. Diagnostic Laboratories
16.3.3. Home-care
16.3.4. Point-of-care
16.3.5. Others
16.4. Market Value Forecast, by Technique, 2017 – 2031
16.4.1. Radioimmunoassay
16.4.2. ELISA
16.4.3. HPLC
16.4.4. LC-MS
16.4.5. Others
16.5. Market Value Forecast, by Patient Type, 2017 – 2031
16.5.1. Adult
16.5.2. Pediatric
16.6. Market Value Forecast, by Indication, 2017 – 2031
16.6.1. Osteoporosis
16.6.2. Rickets
16.6.3. Thyroid disorders
16.6.4. Malabsorption
16.6.5. Vitamin D Deficiency
16.6.6. Others
16.7. Market Value Forecast, by Country/Sub-region, 2017 – 2031
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
16.8.1. By Test Type
16.8.2. By End-user
16.8.3. By Technique
16.8.4. By Patient Type
16.8.5. By Indication
16.8.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player – Competition Matrix (By Tier and Size of companies)
17.2. Market Share Analysis, by Company (2021)
17.3. Company Profiles
17.3.1. DiaSorin S.p.A.
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Financial Analysis
17.3.1.3. Growth Strategies
17.3.1.4. SWOT Analysis
17.3.2. DiaSys Diagnostic Systems GmbH
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Financial Analysis
17.3.2.3. Growth Strategies
17.3.2.4. SWOT Analysis
17.3.3. bioMérieux SA
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Financial Analysis
17.3.3.3. Growth Strategies
17.3.3.4. SWOT Analysis
17.3.4. Bio-Rad Laboratories
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Financial Analysis
17.3.4.3. Growth Strategies
17.3.4.4. SWOT Analysis
17.3.5. Abbott Laboratories
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Financial Analysis
17.3.5.3. Growth Strategies
17.3.5.4. SWOT Analysis
17.3.6. Siemens Healthineers
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Financial Analysis
17.3.6.3. Growth Strategies
17.3.6.4. SWOT Analysis
17.3.7. F. Hoffmann-La Roche Ltd
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Financial Analysis
17.3.7.3. Growth Strategies
17.3.7.4. SWOT Analysis
17.3.8. Thermo Fisher Scientific, Inc.
17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.8.2. Financial Analysis
17.3.8.3. Growth Strategies
17.3.8.4. SWOT Analysis
17.3.9. Quest Diagnostics Incorporated
17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.9.2. Financial Analysis
17.3.9.3. Growth Strategies
17.3.9.4. SWOT Analysis
17.3.10. Danaher Corporation
17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.10.2. Financial Analysis
17.3.10.3. Growth Strategies
17.3.10.4. SWOT Analysis
Table 01: Global Vitamin D Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 02: Global Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 03: Global Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 04: Global Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient Type, 2017–2031
Table 05: Global Vitamin D Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 06: Global Vitamin D Testing Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 07: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 08: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 09: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 10: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient Type, 2017–2031
Table 11: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 12: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 15: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 16: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient Type, 2017–2031
Table 17: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 18: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 19: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 20: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 21: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 22: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient Type, 2017–2031
Table 23: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 24: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 25: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 26: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 27: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 28: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient Type, 2017–2031
Table 29: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 30: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 31: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 32: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 33: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 34: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient Type, 2017–2031
Table 35: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 36: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031